J Bone Miner Res 2013; 28:2266 (Fig. 2)

Slides:

Advertisements

Similar presentations

Chapter 39 Animal Models for Osteoporosis

Advertisements

Chapter 85 Chapter 85 Parathyroid Hormone Treatment for Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.

Bone Quality PART 1 Introduction Architecture Turnover.

Osteoporosis. Types of BMD Tests There are several different machines that measure bone density. Central machines measure density in the hip, spine.

Atypical Fractures of the Femur: Evaluation and Treatment by Travis Blood, R.J. Feller, Eric Cohen, Christopher T. Born, and Roman Hayda JBJS Reviews Volume.

Bone Mineral Density Testing March 29, Introduction Osteoporosis is a systemic skeletal disorder characterized by decreased bone mass and deterioration.

ECTS symposium 5 Anabolic treatment of osteoporosis.

Gaucher Disease: Bone Imaging. DXA (Dual-Energy X-ray Absorptiometry)

June 2004 Bone Quality June 2004 A systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue,

June 2004 Bone Quality Sourced from NIH Consensus Development Panel on Osteoporosis. JAMA 285: ; 2001 Architecture Turnover Rate Damage Accumulation.

AFF: Bone Density and Structure with BP Use Based on Poster FR0030 “Bone Density and Structure of Patients on Bisphosphonates with Atypical Femur Fractures”

Advanced Imaging of Bone Macrostructure and Microstructure in Bone Fragility and Fracture Repair by Banu B. Kalpakcioglu, Saam Morshed, Klaus Engelke,

A Comparison of the Effects of Alendronate and Alfacalcidol on Bone Mineral Density Around the Femoral Implant and in the Lumbar Spine After Total Hip.

Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Benefits of 2 Years of Intense Exercise on Bone Density,

Chapter 7: Assessment of Bone Mass and Microarchitecture in Rodents Blaine A. Christiansen and Mary L. Bouxsein.

Chapter 41: Role of Sex Steroids in the Pathogenesis of Osteoporosis Matthew T. Drake and Sundeep Khosla.

Date of download: 5/31/2016 From: Alendronate and Estrogen–Progestin in the Long-Term Prevention of Bone Loss: Four-Year Results from the Early Postmenopausal.

Predicting Osteoporotic Hip Fractures: In Vitro Study of 80 Femurs Using Three Imaging Methods and Finite Element Modeling -- The European Fracture Study.

Chapter 34: Biochemical Markers of Bone Turnover in Osteoporosis Pawel Szulc and Pierre D. Delmas.

Osteoporosis. Definitions: - - Osteoblasts: Fibroblasts essential for bone formation and mineralization of bone matrix - - Osteoclasts: Cells that break.

Work Performed at Lexicon Pharmaceuticals, Texas, USA

Volume 49, Issue 6, Pages (December 2011)

Copyright © 2005 American Medical Association. All rights reserved.

(The data are from Southard RN, et al

Stem Cells and Osteoporosis

Volume 48, Issue 4, Pages (April 2011)

Chapter 38: Epidemiology of Osteoporotic Fractures

Chapter 61: Transplantation Osteoporosis

Volume 103, Pages (October 2017)

Copyright © 2015 by the American Osteopathic Association.

Lexicon Pharmaceuticals, The Woodlands, TX

Chapter 14: Skeletal Development in Childhood and Adolescence

Goal-directed Treatment for Osteoporosis

The Future of Osteoporosis: Improving Care Along the Way

Effects of the Assessment of 4 Determinants of Structural Geometry on QCT- and DXA- Derived Hip Structural Analysis Measurements in Elderly Women Benjamin.

Effects of Exemestane and Tamoxifen Treatment on Bone Texture Analysis Assessed by TBS in Comparison With Bone Mineral Density Assessed by DXA in Women.

Bone Mineral Density of Healthy Turkish Children and Adolescents

The erlangen fitness osteoporosis prevention study: a controlled exercise trial in early postmenopausal women with low bone density—first-year results

Deena Lala, Angela M. Cheung, Cheryl L

Bone Mineral Density After Spinal Cord Injury: A Reliable Method for Knee Measurement Richard K. Shields, PhD, PT, Janet Schlechte, MD, Shauna Dudley-Javoroski,

The relationships between bone mineral density in the spine, hip, distal femur and proximal tibia and medial minimum joint space width in the knees of.

J Bone Miner Res 2015;30:1553 (Fig. 1)

RANK Ligand-targeted Therapy: A Novel Approach to Prevent Bone Loss and Fractures in Men with Prostate Cancer Matthew R. Smith European Urology Supplements

Treatment Options for Osteoporosis

Vert Non-Vert Hip ** ** Zoledronic Acid3 Zoledronic Acid4 Denosumab5

Ominsky M, Boyce RG, Kosteniuk P, et al 2013 Nf1 Continuous modeling-based bone formation: A novel mechanism that could explain the sustained increases.

Quiz Page Answers November 2005

Bisphosphonate exposure and Atypical Femoral Fractures

Type of Hip Fracture in Patients With Parkinson Disease is Associated With Femoral Bone Mineral Density Marco Di Monaco, MD, Fulvia Vallero, MD, Roberto.

Image with permission from PR Buenzli and NA Sims.

Bone 2013; doi: /j.bone (Fig. 1)

Osteoporos Int 2015;26:2243 (Fig. 2)

Bone 2013;56:23 (Fig. 1) Reproduced from Bone, 56:23-9, Copyright (2013), with permission from Elsevier.

J Bone Miner Res 2013; doi: /jbmr.2072 (Fig. 1)

Reduced bone mineral density in adults treated with high-dose corticosteroids for childhood nephrotic syndrome Janet Hegarty, M. Zulf Mughal, Judith.

G. H. Lo, M. D. , M. Sc. , J. Niu, M. D. , D. Sc. , C. E. McLennan, M

Bone 2014;61:191 (Fig. 2) Reproduced from Bone, 61: , Copyright (2014), with permission from Elsevier.

Testim® Gel: Review of Clinical Data

3D modelling of the hip joint from clinical imaging data

JBMR 2012;doi:[ /jbmr.1760] (Fig. 3A)

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Alendronate on Bone Mineral Density and Bone Remodelling in Perimenopausal.

Cortical thickness mapping of the proximal femur: towards a new imaging biomarker of hip osteoarthritis T.D. Turmezei, G.M. Treece, A.H. Gee, K.E. Poole

M. Kathleen Clark, Ph. D. , MaryFran R. Sowers, Ph. D

Surgery for Obesity and Related Diseases

Change in cortical bone thickness among 64 women with osteopenia randomised to 14-month treatment with no mineral therapy (red bar), calcium gluconate.

Bone 2014;69C:89 (Fig. 2) Reproduced from Bone, 69C:89-97, Copyright (2014), with permission from Elsevier.

3D feature severity mapping of the hip with computed tomography reveals patterns of radiological osteoarthritis T.D. Turmezei, D.J. Lomas, M.A. Hopper,

J Bone Miner Res 2014;doi: /jbmr.2325 (Fig. 2)

Change in bone in patients who were treated with calcium or sevelamer.

Consultant Rheumatologist Imperial College Healthcare

Presentation transcript:

J Bone Miner Res 2013; 28:2266 (Fig. 2) Reproduced from J Bone Miner Res 2013; 28:2266-76 with permission of the American Society of Bone and Mineral Research.

J Bone Miner Res 2013; 28:2266 (Fig. 3) Reproduced from J Bone Miner Res 2013; 28:2266-76 with permission of the American Society of Bone and Mineral Research.

Whitmarsh T, Treece G, Gee A, Poole K 2013 Cortical thickness and density changes over the proximal femur resulting from switching to or combining with teriparatide after prior treatment with raloxifene or alendronate. J Bone Miner Res 28 (Suppl 1). Available at http://www.asbmr.org/asbmr-2013-abstract-detail?aid=6d1bd741-0043-47e0-8808-5468e066c370. Accessed November 25, 2013. Reproduced with permission of the American Society of Bone and Mineral Research.

Genant HK, Boonen S, Bolognese MA, Mautalen C, Brown JP, Recknor C, Goemaere S, Engelke K, Yang YC, Austin M, Grauer A, Libanati C 2013 Effect of romosozumab on lumbar spine and hip volumetric bone mineral density (vBMD) as assessed by quantitative computed tomography (QCT). J Bone Miner Res 28 (Suppl 1). Available at http://www.asbmr.org/asbmr-2013-abstract-detail?aid=67672d13-3ff4-4d27-81cc-eb47f22ecf45. Accessed November 25, 2013. Reproduced with permission of the American Society of Bone and Mineral Research.

Li X, Warmington KS, Niu QT, Dwyer D, Han CY, Stolina M, Grauer A, Ke HZ 2013 Retreatment with sclerostin antibody increased bone formation and bone mass in ovariectomized rats. J Bone Miner Res 28 (Suppl 1). Available at http://www.asbmr.org/asbmr-2013-abstract-detail?aid=339d7b2b-eb9a-46d4-a313-48c681de651e. Accessed November 25, 2013. Reproduced with permission of the American Society of Bone and Mineral Research.